Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

BetterMe Rx vs Tablet Health

BetterMe Rx
Graded #230

Higher grade

vs+17.300000000000004
Tablet Health
Graded #495

Lower grade

The verdict

BetterMe Rx takes it — 64.9/100 to 47.6/100.

BetterMe Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. BetterMe Rx offers compounded semaglutide ($199/mo) and tirzepatide ($299/mo) in both injectable and oral daily tablet formats.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueTablet Health +1
44
45
Dose & formulationBetterMe Rx +24
75
51
Clinical oversightBetterMe Rx +47
84
37
Labs & monitoringBetterMe Rx +2
52
50
FulfillmentBetterMe Rx +31
88
57
Contract termsTablet Health +8
47
55
BetterMe Rx · left barTablet Health · right bar

The numbers

MetricBetterMe RxTablet Health
WeighScore64.9/10047.6/100
GradeCC
Scorecard rank#230#495
Semaglutide$199/mo (promotional rate, compounded)Not disclosed
Tirzepatide$299/mo (promotional rate, compounded)Not disclosed
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesYes
BetterMe Rx

Graded #230 · C

Strengths

  • LegitScript verified
  • All 50 states coverage
  • Six named pharmacy partners with phone numbers — exceptional transparency
  • Both injectable and oral daily tablet formats for sema and tirz
  • Multi-month discounts (3-month and 6-month plans)

Where it loses points

  • No formal corporate entity name or address disclosed
  • Compounded only — no brand-name options
  • Broader platform (HRT, ED, NAD+, Sermorelin, skincare)
  • Headline $199/$299 are limited-time SALE prices; regular prices are $249/$349 per month
Tablet Health

Graded #495 · C

Strengths

  • LegitScript Certified
  • Four named compounding pharmacy partners (Pharmacy Hub, Epiq Scripts, Dr. TelX, Emerad), none with FDA warning letters
  • Oral GLP-1 option for both semaglutide and tirzepatide — uncommon in compounded telehealth
  • Mid-tier pricing starting $179–$299/mo across all four product variants
  • No commitment — cancel anytime

Where it loses points

  • States served not published — you must complete the intake quiz to learn eligibility
  • No founder, CEO, medical director, or pharmacist-in-charge named anywhere
  • No BBB profile found
  • Its Queens NYC pharmacy is 'opening soon' — all dispensing currently routes through external partners
  • FDA issued this company a warning letter dated 19 March 2025; the letter is public in FDA's warning-letter database

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard